Innocoll AG (INNL) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Enanta Pharma (ENTA) Adds Innocoll Holdings' Russell as Director
November 22, 2016 7:40 AM ESTEnanta Pharmaceuticals, Inc. (Nasdaq: ENTA) announced the appointment of Lesley Russell, MBChB, MRCPb, to its Board of Directors. Dr. Russell will also serve as a member of Enantas audit committee and its nominating and corporate governance committee, effective as of January 1, 2017.
Dr. Russell has over two decades of clinical, regulatory and drug development expertise in the therapeutic areas of hematology/oncology, neurology, psychiatry, pain and inflammation, respiratory medicine, cardiovascular medicine, virology and stem cell therapy. Throughout her career and under her leadership, she has advanced multiple drug candidates from preclinical development, through the... More
